| Peer-Reviewed

Design and Implementation of a Cancer Screening Program for a Health District in Sub-Saharan Africa: A Pilot Study

Received: 10 August 2022     Accepted: 17 September 2022     Published: 16 November 2022
Views:       Downloads:
Abstract

The incidence of cancer in Sub-Saharan Africa is increasing and most cancers are diagnosed at advanced stages where treatment is usually less effective, more expensive, and more disabling. Early detection can reduce the burden of this health problem. This paper describes a pilot study to assess the feasibility of implementing a cancer screening program at the Dibombari Health District in Cameroon. A privately owned modern oncology center (Cameroon Oncology Center) located within the health district just outside the city of Douala in the Republic of Cameroon conducted the study. A total of 103 participants including 88 females and 15 males with a median age of 38 years (mean, 41.4 years; range, 17–82 completed years) were screened for cervical, breast and prostate cancers from October 24th to November 12th, 2021. Clinical examination of the breast and prostate for males, and breasts and genitals for females including visual inspections of the cervix with acetic acid then Lugol’s iodine (VIA-VILI) were performed. Thirty-eight (representing 36.9%) of the screened participants had cancer suspicious lesions and accordingly received the following management plans: follow-up breast ultrasound (17 participants); follow-up pelvic ultrasound (7); follow-up microbiopsy (2); follow-up biopsy (1); follow-up Pap smear (9); and prostate-specific antigen test (4 males with enlarged prostate). The remaining 65 participants (63.1%) had no suspicious lesions, and were booked for a review in one year. Our study shows that most of the screened participants with suspicious lesions were asymptomatic. Our findings therefore highlight the feasibility of implementing a comprehensive cancer screening program in the health district given its effectiveness in lessening the burden of this health problem.

Published in International Journal of Clinical Oncology and Cancer Research (Volume 7, Issue 4)
DOI 10.11648/j.ijcocr.20220704.11
Page(s) 83-88
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Cameroon Oncology Center, Cancer Screening, Cervical, Breast, Prostate

References
[1] IARC, World Health Organization International Agency for Research on Cancer, 2021. GLOBOCAN 2020: Estimated cancer incidence, mortality and prevalence worldwide in 2020. https://gco.iarc.fr/today/fact-sheets-populations. Accessed November 5, 2021.
[2] Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pineros M, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020 (https://gco.iarc.fr/today, accessed November 5, 2021).
[3] Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol 2021 June 2. doi: 10.1038/s41571-021-00514-z.
[4] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemel A, Bray F. Global Can Statistics 2020: Globocan estimates of incidence and mortality for 36 cancers in 185 countries. CA Cancer Journal for Clinicians. 2021; 71: 209–249.
[5] World Health Organization. WHO report on cancer: setting priorities, investing wisely and providing care for all (WHO, 2020).
[6] Datta NR, Heuser M, Samiei M, Shah R, Lutters G, Bodis S. Teleradiotherapy Network: Applications and Feasibility for Providing Cost-Effective Comprehensive Radiotherapy Care in Low- and Middle-Income Group Countries for Cancer Patients. Telemedicine and e-Health. 2015; 21: 523–532.
[7] Hajek A, Kretzler B, König H-H. Personality and the use of cancer screenings. A systematic review. PLoS ONE. 2020; 15 (12): e0244655.
[8] Mandal R, Basu P. Cancer screening and early diagnosis in low and middle income countries. Current situation and future perspectives. Bundesgesundheitsbl. 2018; 61: 1505–1512.
[9] Martei YM, Dauda B, Vanderpuye V. Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal. BMC Cancer. 2022; 22: 203.
[10] Black E, Richmond R. Prevention of Cervical Cancer in Sub-Saharan Africa: The Advantages and Challenges of HPV Vaccination. Vaccines. 2018; 6: 61–68.
[11] Carter SM, Williams J, Parker L, Pickels K, Jacklyn G, Rychetnik L, Barratt A. Screening for Cervical, Prostate, and Breast Cancer. Interpreting the Evidence. Am J Prev Med. 2015; 49: 274–285.
[12] WHO World Health Organization, editor. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization; 2013.
[13] Abuidris DO, Elsheikh A, Ali M, Musa H, Elgaili E, Ahmed AO, Sulieman I, Mohammed SI. Breast-cancer screening with trained volunteers in a ruralarea of Sudan: a pilot study. Lancet Oncol. 2013; 14: 363–70.
[14] Sankaranarayanan R. Screening for Cancer in Low- and Middle-Income Countries. Annals of Global Health. 2014; 80: 412-417.
[15] Gele AA, Qureshi SA, Kour P, Kumar B, Diaz E. Int J Women’s Health. 2017: 9: 487–496.
[16] Veins L, Perin D, Senkomago V, Neri A, Saraiya M. Questions About Cervical and Breast Cancer Screening Knowledge, Practice, and Outcomes: A Review of Demographic and Health Surveys. J Womens Health (Larchmt). 2017; 26 (5): 403–412.
[17] Yoon S, Wang K, Luo Y, Lee J, Neese J, Yun Lee HY. Cancer Screening Literacy among Vietnamese Population: Does Annual Checkup Improve Cancer Screening Literacy? Asian Pac J Cancer Prev. 2021; 22 (3): 927–933.
[18] Corbex M, Burton R, Sancho-Garnier H. Breast cancer early detection methods for low and middle income countries, a review of the evidence. The Breast. 2012; 21 (4): 428–34.
[19] Sankaranarayanan R, Ramadas K, Thara S, et al. Clinical Breast Examination: Preliminary Results from a Cluster Randomized Controlled Trial in India. JNCI Journal of the National Cancer Institute. 2011; 103 (19): 1476–80.
[20] Tassang A, Halle-Ekane GE, Nembulefack D, Enow-orock G, et al. Cervical cancer screening in a low-resource setting: Buea-Cameroon. International Research Journal of Oncology. 2020; 3 (3): 47–55.
[21] Sharma P, Pattanshetty SM. A study on risk factors of cervical cancer among patients attending a tertiary care hospital: A case-control study. Clinical Epidemiology and Global health 2017. https://doi.org/10.1016/j.cegh.2017.10.001
[22] Miller AM, Barclay THC, Choi NW, Grace MG et al. A study of cancer, parity and age at first pregnancy. Journal of Chronic Diseases. 1980; 33 (10): 595–605.
[23] Mobit PN, Ade N. Commissioning Experience of a Medical Linear Accelerator in a Low-Resource Setting in Sub-Saharan Africa. Radiation Science and Technology. 2022; 8: 30–37.
[24] Mobit PN, Imandi PH, Ade N. End-to-End Test for a Radiotherapy Program Based on the Medical Linear Accelerator Installed in a Resource-Limited Oncology Centre in Sub-Saharan Africa. Radiation Science and Technology. 2022; 8 (2): 22–29.
[25] Mobit P, Mourad W, Folefac E, Yan W, Ade N, et al. Introduction of a Hybrid Tele-oncology Program in a Low-Resource Setting in Sub-Saharan Africa. In Press, International Journal of Clinical Oncology and Cancer Research. 2022; 7: 70–75.
Cite This Article
  • APA Style

    Sylvester Adeh Nsoh, Paul Mobit, Nicholas Ade, Mc Che Joe Brown, Ambe Yancho, et al. (2022). Design and Implementation of a Cancer Screening Program for a Health District in Sub-Saharan Africa: A Pilot Study. International Journal of Clinical Oncology and Cancer Research, 7(4), 83-88. https://doi.org/10.11648/j.ijcocr.20220704.11

    Copy | Download

    ACS Style

    Sylvester Adeh Nsoh; Paul Mobit; Nicholas Ade; Mc Che Joe Brown; Ambe Yancho, et al. Design and Implementation of a Cancer Screening Program for a Health District in Sub-Saharan Africa: A Pilot Study. Int. J. Clin. Oncol. Cancer Res. 2022, 7(4), 83-88. doi: 10.11648/j.ijcocr.20220704.11

    Copy | Download

    AMA Style

    Sylvester Adeh Nsoh, Paul Mobit, Nicholas Ade, Mc Che Joe Brown, Ambe Yancho, et al. Design and Implementation of a Cancer Screening Program for a Health District in Sub-Saharan Africa: A Pilot Study. Int J Clin Oncol Cancer Res. 2022;7(4):83-88. doi: 10.11648/j.ijcocr.20220704.11

    Copy | Download

  • @article{10.11648/j.ijcocr.20220704.11,
      author = {Sylvester Adeh Nsoh and Paul Mobit and Nicholas Ade and Mc Che Joe Brown and Ambe Yancho and Isabella Fri Tayong},
      title = {Design and Implementation of a Cancer Screening Program for a Health District in Sub-Saharan Africa: A Pilot Study},
      journal = {International Journal of Clinical Oncology and Cancer Research},
      volume = {7},
      number = {4},
      pages = {83-88},
      doi = {10.11648/j.ijcocr.20220704.11},
      url = {https://doi.org/10.11648/j.ijcocr.20220704.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20220704.11},
      abstract = {The incidence of cancer in Sub-Saharan Africa is increasing and most cancers are diagnosed at advanced stages where treatment is usually less effective, more expensive, and more disabling. Early detection can reduce the burden of this health problem. This paper describes a pilot study to assess the feasibility of implementing a cancer screening program at the Dibombari Health District in Cameroon. A privately owned modern oncology center (Cameroon Oncology Center) located within the health district just outside the city of Douala in the Republic of Cameroon conducted the study. A total of 103 participants including 88 females and 15 males with a median age of 38 years (mean, 41.4 years; range, 17–82 completed years) were screened for cervical, breast and prostate cancers from October 24th to November 12th, 2021. Clinical examination of the breast and prostate for males, and breasts and genitals for females including visual inspections of the cervix with acetic acid then Lugol’s iodine (VIA-VILI) were performed. Thirty-eight (representing 36.9%) of the screened participants had cancer suspicious lesions and accordingly received the following management plans: follow-up breast ultrasound (17 participants); follow-up pelvic ultrasound (7); follow-up microbiopsy (2); follow-up biopsy (1); follow-up Pap smear (9); and prostate-specific antigen test (4 males with enlarged prostate). The remaining 65 participants (63.1%) had no suspicious lesions, and were booked for a review in one year. Our study shows that most of the screened participants with suspicious lesions were asymptomatic. Our findings therefore highlight the feasibility of implementing a comprehensive cancer screening program in the health district given its effectiveness in lessening the burden of this health problem.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Design and Implementation of a Cancer Screening Program for a Health District in Sub-Saharan Africa: A Pilot Study
    AU  - Sylvester Adeh Nsoh
    AU  - Paul Mobit
    AU  - Nicholas Ade
    AU  - Mc Che Joe Brown
    AU  - Ambe Yancho
    AU  - Isabella Fri Tayong
    Y1  - 2022/11/16
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ijcocr.20220704.11
    DO  - 10.11648/j.ijcocr.20220704.11
    T2  - International Journal of Clinical Oncology and Cancer Research
    JF  - International Journal of Clinical Oncology and Cancer Research
    JO  - International Journal of Clinical Oncology and Cancer Research
    SP  - 83
    EP  - 88
    PB  - Science Publishing Group
    SN  - 2578-9511
    UR  - https://doi.org/10.11648/j.ijcocr.20220704.11
    AB  - The incidence of cancer in Sub-Saharan Africa is increasing and most cancers are diagnosed at advanced stages where treatment is usually less effective, more expensive, and more disabling. Early detection can reduce the burden of this health problem. This paper describes a pilot study to assess the feasibility of implementing a cancer screening program at the Dibombari Health District in Cameroon. A privately owned modern oncology center (Cameroon Oncology Center) located within the health district just outside the city of Douala in the Republic of Cameroon conducted the study. A total of 103 participants including 88 females and 15 males with a median age of 38 years (mean, 41.4 years; range, 17–82 completed years) were screened for cervical, breast and prostate cancers from October 24th to November 12th, 2021. Clinical examination of the breast and prostate for males, and breasts and genitals for females including visual inspections of the cervix with acetic acid then Lugol’s iodine (VIA-VILI) were performed. Thirty-eight (representing 36.9%) of the screened participants had cancer suspicious lesions and accordingly received the following management plans: follow-up breast ultrasound (17 participants); follow-up pelvic ultrasound (7); follow-up microbiopsy (2); follow-up biopsy (1); follow-up Pap smear (9); and prostate-specific antigen test (4 males with enlarged prostate). The remaining 65 participants (63.1%) had no suspicious lesions, and were booked for a review in one year. Our study shows that most of the screened participants with suspicious lesions were asymptomatic. Our findings therefore highlight the feasibility of implementing a comprehensive cancer screening program in the health district given its effectiveness in lessening the burden of this health problem.
    VL  - 7
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Department of Obstetrics and Gynaecology, Cameroon Oncology Center, Douala, Cameroon

  • Department of Radiation Oncology, Cameroon Oncology Center, Douala, Cameroon

  • Department of Radiation Oncology, Cameroon Oncology Center, Douala, Cameroon

  • Department of General Medicine, Cameroon Oncology Center, Douala, Cameroon

  • Department of General Medicine, Cameroon Oncology Center, Douala, Cameroon

  • Cameroon Cancer Foundation, Douala, Cameroon

  • Sections